trending Market Intelligence /marketintelligence/en/news-insights/trending/gcbz60PeLZJ6bDuklKQgWw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Dermira plans $110M common stock offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Dermira plans $110M common stock offering

Dermira Inc. plans to sell $110 million of its common shares in an underwritten public offering.

The biopharmaceutical company plans to grant the underwriters an option to buy up to an additional $16.5 million of its common stock in the offering.

Citigroup, Cowen, Cantor Fitzgerald & Co. and Guggenheim Securities are acting as book-runners, with Needham & Co. and H.C. Wainwright & Co. as co-managers.

Menlo Park, Calif.-based Dermira develops and commercializes therapies for patients with skin conditions. The company offers Qbrexza for the treatment of primary axillary hyperhidrosis — a certain condition in which excessive sweating occurs — in adults and pediatric patients nine years and older.